577 filings
Page 2 of 29
8-K
pv5imdzlmrn0f 4nn
20 Dec 22
Regulation FD Disclosure
7:05am
CT ORDER
ozgtxvoxi4hp90n 7mp
29 Nov 22
Confidential treatment order
12:25pm
8-K
o32ipfa
10 Nov 22
Altimmune Announces Third Quarter 2022 Financial Results and Provides a Business Update
7:06am
8-K
1xnvg
29 Sep 22
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
sydxythbsg q0tkb
14 Sep 22
Regulation FD Disclosure
7:13am
8-K
fncjxeg
11 Aug 22
Altimmune Announces Second Quarter 2022 Financial Results and Provides a Business Update
7:09am
8-K
fk9cvshu b3ncs0
12 May 22
Altimmune Announces First Quarter 2022 Financial Results and Provides a Corporate Update
7:07am
S-8
cmmre6mo8
15 Mar 22
Registration of securities for employees
4:26pm
8-K
lty9nc4gp88egs7g 6z
15 Mar 22
Altimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
7:07am
8-K
2gsgppmi 3o0np6p
17 Dec 21
Termination of a Material Definitive Agreement
5:15pm
8-K
pty7ox sk
13 Dec 21
Altimmune Appoints Richard Eisenstadt as Chief Financial Officer
6:30am
8-K
4h9xjyznvl4u
9 Nov 21
Altimmune Announces Third Quarter 2021 Financial Results
4:08pm
8-K
v3urs
28 Sep 21
Altimmune Announces Positive Results From 12-week Phase 1 Clinical Trial of
7:10am